StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Cerenome's ebitda for the twelve months ending Jun 30, 2026 was -$25.95M. For fiscal 2025 it was -$14.85M. The highest annual figure on record is -$2.76M in fiscal 2019.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.85M–
FY2024Dec 31, 2024-$13.82M–
FY2023Dec 31, 2023-$12.69M–
FY2022Dec 31, 2022-$19.09M–
FY2021Dec 31, 2021-$12.10M–
FY2020Dec 31, 2020-$9.22M–
FY2019Dec 31, 2019-$2.76M–
FY2018Dec 31, 2018-$6.76M–
FY2017Dec 31, 2017-$18.53M–
FY2016Dec 31, 2016-$18.52M–
FY2015Dec 31, 2015-$14.19M–
FY2014Dec 31, 2014-$31.66M–
FY2013Dec 31, 2013-$29.05M–
FY2012Dec 31, 2012-$27.49M–
FY2011Dec 31, 2011-$28.56M–
FY2010Dec 31, 2010-$24.39M–
FY2009Dec 31, 2009-$19.87M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.92M–
Q1 FY2026Mar 31, 2026-$7.02M–
Q4 FY2025Dec 31, 2025-$5.60M–
Q3 FY2025Sep 30, 2025-$4.41M–
Q2 FY2025Jun 30, 2025-$1.46M–
Q1 FY2025Mar 31, 2025-$3.39M–
Q4 FY2024Dec 31, 2024-$3.55M–
Q3 FY2024Sep 30, 2024-$3.60M–
Q2 FY2024Jun 30, 2024-$3.53M–
Q1 FY2024Mar 31, 2024-$3.14M–
Q4 FY2023Dec 31, 2023-$3.71M–
Q3 FY2023Sep 30, 2023-$3.09M–
Q2 FY2023Jun 30, 2023-$1.33M–
Q1 FY2023Mar 31, 2023-$4.56M–
Q4 FY2022Dec 31, 2022-$5.41M–
Q3 FY2022Sep 30, 2022-$4.94M–
Q2 FY2022Jun 30, 2022-$4.97M–
Q1 FY2022Mar 31, 2022-$3.78M–
Q4 FY2021Dec 31, 2021-$3.81M–
Q3 FY2021Sep 30, 2021-$3.41M–
Q2 FY2021Jun 30, 2021-$2.48M–
Q1 FY2021Mar 31, 2021-$2.39M–
Q4 FY2020Dec 31, 2020-$3.30M–
Q3 FY2020Sep 30, 2020-$1.31M-146.1%
Q2 FY2020Jun 30, 2020-$2.26M–
Q1 FY2020Mar 31, 2020-$2.35M–
Q4 FY2019Dec 31, 2019-$2.10M–
Q3 FY2019Sep 30, 2019$2.84M–
Q2 FY2019Jun 30, 2019-$1.79M–
Q1 FY2019Mar 31, 2019-$1.72M–
Q4 FY2018Dec 31, 2018-$1.37M–
Q1 FY2018Mar 31, 2018-$3.86M–
Q4 FY2017Dec 31, 2017-$3.10M–
Q3 FY2017Sep 30, 2017-$3.78M–
Q2 FY2017Jun 30, 2017-$4.97M–
Q1 FY2017Mar 31, 2017-$6.69M–
Q4 FY2016Dec 31, 2016-$3.20M–
Q3 FY2016Sep 30, 2016-$4.58M–
Q2 FY2016Jun 30, 2016-$5.94M–

More Cerenome figures

See a number that looks wrong?